OOIR: Observatory of International Research

Papers

(The TQCC of Biologicals is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Aims and Scope/Editorial Board/Publishing Details	21
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop	21
EGF domain peptide of Developmentally regulated endothelial locus1 facilitates gene expression of extracellularly applied plasmid DNA	15
The development and establishment of a heat inactivated preparation of Mycobacterium tuberculosis (H37Rv) as the first international standard for nucleic acid amplification techniques	12
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Reports from a series of NC3Rs stakeholder workshops	12
Production and characterization of monoclonal antibodies against hepatitis B e-antigen and their potential application for development of HBeAg detection ELISA	11
Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model	11
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis	11
Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression	11
A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency	11
Aims and Scope/Editorial Board/Publishing Details	10
Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab	9
Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report	8
Global availability of critical reagents for biologicals testing - Current status, challenges and possible solutions	8
Vaccination and surveillance for high pathogenicity avian influenza in poultry—current situation and perspectives	8
Validation of a next generation sequencing method for adventitious virus detection: Demonstration of sensitivity in multiple cell lines	8
A species-independent indirect-ELISA for detection of antibodies to the non-structural protein 2B of foot-and-mouth disease virus	8
Establishing potency and stability release specifications using alternative ATP assay of BCG Tokyo 172-1 vaccine used in Thailand	7
The future of pyrogenicity testing: Phasing out the rabbit pyrogen test. A meeting report	7
Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics	7
Ethical approval for controlled human infectious model clinical trial protocols – A workshop report	7
Replacement of in vivo leptospirosis vaccine potency testing in the United States	7
Animal cell substrates for the production of biologicals: An introduction to WHO documents	7
IABS/DCVMN webinar on next generation sequencing	6
Collaborative study for the calibration of a replacement International Standard for Diphtheria Antitoxin Equine	6

Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report	6
A rapid and simple sterility test method based on solid culture medium containing blood	6
Evaluation of candidate International Standards for meningococcal capsular polysaccharide groups W and Y	6
In silico discovery of epitopes of gag and env proteins for the development of a multi-epitope vaccine candidate against Maedi Visna Virus using reverse vaccinology approach	6
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals	6
Development and comparison of three cell-based potency assays for anti-respiratory syncytial virus monoclonal antibody	5
Development and evaluation of an external quality control and internal quality control containing real-time RT-PCR assay for the detection of o'nyong-nyong virus	5
Novel vaccine candidates of Bordetella pertussis identified by reverse vaccinology	5
Evaluation of the focus reduction neutralization and ELISA tests compared to the plaque reduction neutralization test for the detection of antibodies against measles virus	5
Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients	5
Aims and Scope/Editorial Board/Publishing Details	5
Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines	4
Mass spectrometry analysis of bovine tuberculins - 3R potential in batch potency testing	4
Aims and Scope/Editorial Board/Publishing Details	4
Aims and Scope/Editorial Board/Publishing Details	4
Assessment of the risks associated with the use of in vivo versus in vitro potency tests for vaccines	3
Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities	3
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities	3
Report for the Eighth Asian National Control Laboratory Network meeting in 2023: Self-sufficiency strategy of plasma-derived medicinal products and regulatory harmonisation	3
Risk assessment for biopharmaceutical single-use manufacturing: A case study of upstream continuous processing	3
Obituary - Inessa LEVENBOOK: 1926–2022	3
Future of TABST and LABST in the Indian Pharmacopoeia Monographs A Humane Society International/India Workshop Report	3
Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development?	3
Aims and Scope/Editorial Board/Publishing Details	3
Prevalence of viral agents causing swine reproductive failure in Korea and the development of multiplex real-time PCR and RT-PCR assays	3
Development of an optimized RT-LAMP test for the detection of SARS-CoV-2	3
Glycoconjugate content quantification to assess vaccine potency: A simplified approach	3
The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report	3
Aims and Scope/Editorial Board/Publishing Details	3
From eradication to re-emergence: The changing landscape of polio in the cVDPV2 era	3
Enabling the evaluation of COVID-19 vaccines with correlates of protection	3